7Sanon A Tounaire Toumaire-Arellano C El HageSY,et al.N-acetyl-beta-D-hexosam in idase fromT richomonas vaginalis substrate specificity and activity of inhibitors[J].Biomed Pharmacother,2005,59(9):245.
2Menard JP. Antibacterial treatment of bacterial vaginosis: current and endenerging therapies Int J Women' s Heahh, 2011,3 (3) :295 - 305.
3Machado A,Cerca N.Influence of biofilm formation by gardnerella vaginalis and other anaerobes on bacterial vaginosis[J].J Infect Dis,2015,212(12):1856-1861.
4Vitali B,Cruciani F,Picone G,et al.Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis[J].Eur J Clin Microbiol Infect Dis,2015,34(12):2367-2376.
5Sopracordevole F,Mancioli F,Clemente N,et al.Abnormal pap smear and diagnosis of high-grade vaginal intraepithelial neoplasia:a retrospective cohort study[J].Medicine,2015,94(42):e1827.
6Pellett Madan R,Dezzutti CS,Rabe L,et al.Soluble immune mediators and vaginal bacteria impact innate genital mucosal antimicrobial activity in young women[J].Am J Reprod Immunol,2015,74(4):323-332.
